RSV prevention in adults: NIP listing for older adult RSV vaccine

Description

In this Product Explainer, A/Prof Michael Woodward AM, Geriatrician, outlines NIP eligibility criteria and provides practical guidance on recombinant, adjuvanted RSV vaccination, administration and co-administration in older adults (5 mins).

This educational video was developed by Healthed in collaboration with and with funding from GSK.
Views of the speaker are their own and do not necessarily reflect that of GSK. GSK recommends usage in accordance with the Product Information.

Abbreviations: NIP; National Immunisation Program; RSV, respiratory syncytial virus.

PM-AU-RSA-WCNT-260011. Date of approval: May 2026.

Icon 2

NEXT LIVE Webcast

:
Days
:
Hours
:
Minutes
Seconds
Dr Ted Wu

Dr Ted Wu

Oral GLP1s – What GPs Need to Know

Dr Paige Lanyon-Roberts

Dr Paige Lanyon-Roberts

The New Oral Medications for Obesity – A Practical Guide for GPs

Dr Katherine Spira

Dr Katherine Spira

Menstrual Migraine

Prof Danny Green

Prof Danny Green

GLP1s and Muscle Mass – What Does the Evidence Show?

Join us for the next free webcast for GPs and healthcare professionals

High quality lectures delivered by leading independent experts

A/Prof Michael Woodward AM

expert

A/Prof Michael Woodward AM

Geriatrician; Director, Dementia Research, Austin Health

Date published: 4 June 2026